Per sources, Altria Group, Inc (NYSE:MO) is interested in investing in the Canadian cannabis company, Cronos Group Inc (NASDAQ:CRON) . However, Altria has made no official comments on this matter. Per industry experts, the companies are engaged in initial discussions regarding a potential deal. Let’s wait and see if the market hearsay takes shape and how it impacts the tobacco giant’s performance.
Prospects From Cannabis
Persistent regulatory pressure on tobacco consumption along with mass awareness about negative impacts of nicotine has lowered cigarette consumption rates significantly. This has been marring the performance of several tobacco players. Such aspects have compelled companies like Altria to explore other business advents for sustenance. In this respect, the company has been apparently considering to venture into the nascent but booming cannabis industry.
Well, this is not the first time that Altria has been interested in the marijuana sector. In October, there were rounds that the tobacco giant is considering to buy a stake in Aphria Inc. — another major cannabis producer in Canada.
Moreover, with the legalization of recreational use of marijuana in Canada, many companies are foraying into the cannabis space. In fact, companies have been monitoring the health impacts of cannabis and have started viewing cannabis-infused products as another recreational option.
Although Altria is the first tobacco player to depict an interest in cannabis, it appears to be behind behemoths from the beverage arena. Few months back, Constellation Brands (NYSE:STZ) invested in Canada’s Canopy Growth Corp. Also, Coca-Cola (NYSE:KO) is eyeing prospects in the market and plans to make an entry through investment in Aurora Cannabis. That said, it is yet to be seen what type of cannabis offerings Altria will come up with and how it markets them, if the company actually invests in Cronos.
Wrapping Up
Notably, Altria has been consistently taking robust strides to stay afloat in the tobacco space on the back of effective pricing and expansion in the e-cigarette’s arena. This Zacks Rank #3 (Hold) company’s e-vapor products like MarkTen and Green Smoke are performing well in the smokeless category. In fact, sources are speculating that Altria might be considering investment in the e-cigarette company, Juul Labs, Inc. Also, the company’s entry into the cannabis space is likely to provide it significant growth opportunities and boost brand portfolio. We expect that such well-chalked efforts will revive the company’s stock that has lost 6.9% in the past three months, almost in line with the the industry’s fall.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.
See Them Free>>
Constellation Brands Inc (STZ): Free Stock Analysis Report
Coca-Cola Company (The) (KO): Free Stock Analysis Report
Altria Group, Inc. (MO): Free Stock Analysis Report
Cronos Group Inc. (CRON): Free Stock Analysis Report
Original post
Zacks Investment Research